These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10403913)

  • 1. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice.
    Shinomiya M; Fazle Akbar SM; Shinomiya H; Onji M
    Clin Exp Immunol; 1999 Jul; 117(1):38-43. PubMed ID: 10403913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
    Yoon JW; Jun HS
    Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
    Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
    Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
    Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
    J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.
    Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma affects homing of diabetogenic T cells.
    Savinov AY; Wong FS; Chervonsky AV
    J Immunol; 2001 Dec; 167(11):6637-43. PubMed ID: 11714835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.
    Ablamunits V; Elias D; Cohen IR
    Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.
    Rabinovitch A
    Diabetes Metab Rev; 1998 Jun; 14(2):129-51. PubMed ID: 9679667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells in the autoimmune insulitis in NOD mouse models of diabetes.
    Rosmalen JG; Leenen PJ; Katz JD; Voerman JS; Drexhage HA
    Adv Exp Med Biol; 1997; 417():291-4. PubMed ID: 9286375
    [No Abstract]   [Full Text] [Related]  

  • 12. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
    Ablamunits V; Elias D; Reshef T; Cohen IR
    J Autoimmun; 1998 Feb; 11(1):73-81. PubMed ID: 9480725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse.
    Sempé P; Ezine S; Marvel J; Bédossa P; Richard MF; Bach JF; Boitard C
    Int Immunol; 1993 May; 5(5):479-89. PubMed ID: 8318452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
    Pankewycz O; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse.
    Saxena V; Ondr JK; Magnusen AF; Munn DH; Katz JD
    J Immunol; 2007 Oct; 179(8):5041-53. PubMed ID: 17911589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-tau inhibits the development of diabetes in NOD mice.
    Sobel DO; Ahvazi B; Amjad F; Mitnaul L; Pontzer C
    Autoimmunity; 2008 Nov; 41(7):543-53. PubMed ID: 18608174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse.
    Campbell IL; Oxbrow L; Harrison LC
    J Autoimmun; 1991 Apr; 4(2):249-62. PubMed ID: 1909136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant role for Fas in the pathogenesis of autoimmune diabetes.
    Su X; Hu Q; Kristan JM; Costa C; Shen Y; Gero D; Matis LA; Wang Y
    J Immunol; 2000 Mar; 164(5):2523-32. PubMed ID: 10679090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
    Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells.
    Yoon JW; Jun HS; Santamaria P
    Autoimmunity; 1998; 27(2):109-22. PubMed ID: 9583742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.